Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Jacobson Pharma Corp. Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2023 is 11.91% vs 10.35% in Mar 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2023 is 50.88% vs 0.75% in Mar 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "Mar'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,785.60",
          "val2": "1,595.50",
          "chgp": "11.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "503.60",
          "val2": "415.50",
          "chgp": "21.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "67.40",
          "val2": "25.70",
          "chgp": "162.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "34.40",
          "val2": "9.10",
          "chgp": "278.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "283.20",
          "val2": "187.70",
          "chgp": "50.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "178.70%",
          "val2": "139.70%",
          "chgp": "3.90%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Mar'23

Mar'23

Mar'22

Change(%)

Net Sales

1,785.60

1,595.50

11.91%

Operating Profit (PBDIT) excl Other Income

503.60

415.50

21.20%

Interest

67.40

25.70

162.26%

Exceptional Items

34.40

9.10

278.02%

Consolidate Net Profit

283.20

187.70

50.88%

Operating Profit Margin (Excl OI)

178.70%

139.70%

3.90%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2023 is 11.91% vs 10.35% in Mar 2022

Consolidated Net Profit

YoY Growth in year ended Mar 2023 is 50.88% vs 0.75% in Mar 2022

All Annual Results